Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-08-10, Stock:LLY, The news for the past five days is as follows:
2020-08-03: NEWS1: Regeneron says antibody cocktail prevents and treats COVID-19 in animals.NEWS2: U.S. Cases Increase 0.9%; California, Arizona Slow: Virus Update.NEWS3: Eli Lilly Stock Jumps As Coronavirus Drug Enters Phase 3 Testing.NEWS4: Coronavirus update: Birx in Trump's crosshairs for 'new phase' as WHO warns on vaccine hopes.NEWS5: COVID-19 is 'running rampant in poorer communities': Fmr. CDC official.NEWS6: Stocks Climb to Start the Month as New Virus Cases Fall.NEWS7: The Vanguard Health Care Fund Cuts Eli Lilly, Merck & Co..NEWS8: Nasdaq Races to Record High as Big Tech Reigns Supreme.NEWS9: Eli Lilly Begins Phase III Trial of Antibody Against Covid-19.NEWS10: Eli Lilly Stock Is Rising as the Company Tests a Covid-19 Antibody Drug In Nursing Homes.NEWS11: Dow Gains as Big Tech Continues Reign; Microsofts Jumps on TikTok Talks.NEWS12: GLOBAL MARKETS-Summer mood swings: markets turn higher on hopes of virus aid.NEWS13: Eli Lilly Kicks Off Covid-19 Antibody Trial In Nursing Home Residents.NEWS14: Lilly's stock rises as it announces late-stage trial for COVID-19 drug in nursing homes.NEWS15: FOCUS-Next big COVID-19 treatment may be manufactured antibodies.NEWS16: Lilly starts late-stage study of COVID-19 drug in nursing homes.NEWS17: Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID).NEWS18: Rival drugmakers launch joint trial of medicines for COVID-19.NEWS19: Stocks - Microsoft, Marathon Petroleum Rise Premarket; HSBC Falls.
2020-08-04: NEWS1: Eli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study.NEWS2: Incyte Earnings Soar 65%, Easily Beating Views.NEWS3: Trending Market News Tuesday: Facebook, Eli Lilly, Activision.NEWS4: NIH to launch trials to test antibody drugs for COVID-19.NEWS5: Morning Bell With Jim Cramer: TikTok Will Help Microsoft.NEWS6: Eli Lilly Brings a Coronavirus Drug Study Directly to Senior Care Facilities -- in RVs.NEWS7: Pharma Stocks in Focus on Late-Stage Coronavirus Vaccine Trials.NEWS8: Better Coronavirus Stock: Regeneron or Eli Lilly?.NEWS9: Regeneron Pharmaceuticals Reports Earnings Tomorrow. Here’s What to Expect..
2020-08-05: NEWS1: The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech.NEWS2: Empagliflozin meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in Phase III trial in adults with and without diabetes.NEWS3: NIH to test Lilly's experimental monoclonal antibody treatment in mild and moderate COVID-19 cases.
2020-08-06: NEWS1: ‘We need to make sure that the science and safety is there’ so people can trust the vaccine: doctor.NEWS2: Early Sales of Eli Lilly's Migraine Drug Disappoint.NEWS3: Top Stock Reports for Apple, Mastercard & Eli Lilly.
2020-08-07: NEWS1: Pharma ETFs Soar on Robust Q2 Earnings.NEWS2: Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus.NEWS3: The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev.NEWS4: NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment.

Answer: Rise